Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Reperfusion injury
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Metformin === A series of 2009 studies published in the Journal of Cardiovascular Pharmacology suggest that [[Metformin]] may prevent cardiac reperfusion injury by inhibition of [[Electron transport chain|Mitochondrial Complex I]] and the opening of MPT pore and in rats.<ref>{{cite journal |last1=Paiva |first1=Marta |last2=Riksen |first2=Niels P |last3=Davidson |first3=Sean M |last4=Hausenloy |first4=Derek J |last5=Monteiro |first5=Pedro |last6=Gonçalves |first6=Lino |last7=Providência |first7=Luís |last8=Rongen |first8=Gerard A |last9=Smits |first9=Paul |last10=Mocanu |first10=Mihaela M |last11=Yellon |first11=Derek M |title=Metformin Prevents Myocardial Reperfusion Injury by Activating the Adenosine Receptor |journal=Journal of Cardiovascular Pharmacology |date=May 2009 |volume=53 |issue=5 |pages=373–378 |doi=10.1097/FJC.0b013e31819fd4e7 |pmid=19295441 |s2cid=21161059 }}</ref><ref>{{cite journal |last1=Bhamra |first1=Gurpreet S. |last2=Hausenloy |first2=Derek J. |last3=Davidson |first3=Sean M. |last4=Carr |first4=Richard D. |last5=Paiva |first5=Marta |last6=Wynne |first6=Abigail M. |last7=Mocanu |first7=Mihaela M. |last8=Yellon |first8=Derek M. |title=Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening |journal=Basic Research in Cardiology |date=May 2008 |volume=103 |issue=3 |pages=274–284 |doi=10.1007/s00395-007-0691-y |pmid=18080084 |s2cid=28815693 }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)